Squamous cell lung carcinoma patients showed a no significant increased incidence of moderate/high EphA4 compared to those with adenocarcinoma (Table 1), while moderate/high EphA5 and A7 expression was more frequently observed in lung adenocarcinoma patients compared to those with squamous cell carcinoma (Table 2). This evidence concerns the gene EPHA5 and adenocarcinoma.